![](/img/cover-not-exists.png)
Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer
Paulo M. Hoff, Robert A. Wolff, Henry Xiong, Dennie Jones, Edward Lin, Cathy Eng, Ankhi Dutta, Karla R. Bogaard, James L. AbbruzzeseVolume:
106
Year:
2006
Language:
english
Pages:
6
DOI:
10.1002/cncr.21874
File:
PDF, 92 KB
english, 2006